$171 Million is the total value of Birchview Capital, LP's 0 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 17.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Sell | CELGENE CORP | $81,210,000 | +5.7% | 777,051 | -0.3% | 47.40% | -15.0% |
| AXDX | ACCELERATE DIAGNOSTICS INC | $59,312,000 | +89.4% | 2,175,795 | 0.0% | 34.62% | +52.3% | |
| VRML | VERMILLION INC | $3,533,000 | +17.1% | 2,717,514 | 0.0% | 2.06% | -5.8% | |
| EQT | EQT CORP | $3,072,000 | -6.2% | 42,300 | 0.0% | 1.79% | -24.6% | |
| BIOL | BIOLASE INC | $2,250,000 | +49.5% | 1,285,903 | 0.0% | 1.31% | +20.1% | |
| MASI | MASIMO CORP | $2,177,000 | +13.3% | 36,600 | 0.0% | 1.27% | -8.9% | |
| CFRX | Buy | CONTRAFECT CORP | $1,798,000 | +31.0% | 725,082 | +52.6% | 1.05% | +5.2% |
| ECA | ENCANA CORP | $1,385,000 | +34.3% | 132,300 | 0.0% | 0.81% | +8.0% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $1,276,000 | +11.4% | 25,200 | 0.0% | 0.74% | -10.3% | |
| TSRO | Buy | TESARO INC | $997,000 | +40.4% | 9,950 | +17.8% | 0.58% | +13.0% |
| MRK | MERCK & CO INC | $936,000 | +8.3% | 15,000 | 0.0% | 0.55% | -12.9% | |
| MBLX | METABOLIX INC RESTRICTED | $917,000 | -45.8% | 2,263,166 | 0.0% | 0.54% | -56.4% | |
| QDEL | QUIDEL CORP | $861,000 | +23.7% | 38,975 | 0.0% | 0.50% | -0.4% | |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $845,000 | +66.7% | 67,303 | +19.5% | 0.49% | +34.0% |
| OMED | ONCOMED PHARMACEUTICALS INC | $808,000 | -7.1% | 70,689 | 0.0% | 0.47% | -25.3% | |
| T107PS | WRIGHT MEDICAL GROUP NV | $736,000 | +41.3% | 30,000 | 0.0% | 0.43% | +13.8% | |
| NXTM | NXSTAGE MEDICAL INC | $705,000 | +15.4% | 28,200 | 0.0% | 0.41% | -7.4% | |
| SITOQ | Buy | SITO MOBILE LTD | $616,000 | +755.6% | 140,000 | +600.0% | 0.36% | +592.3% |
| ARAY | ACCURAY INC | $607,000 | +22.6% | 95,300 | 0.0% | 0.35% | -1.4% | |
| SIEN | SIENTRA INC | $569,000 | +36.5% | 63,300 | 0.0% | 0.33% | +9.6% | |
| PXD | PIONEER NATURAL RESOURCES CO (PXD) | $557,000 | +22.1% | 3,000 | 0.0% | 0.32% | -1.8% | |
| COG | CABOT OIL & GAS CORP | $542,000 | +0.2% | 21,000 | 0.0% | 0.32% | -19.6% | |
| CORT | CORCEPT THERAPEUTICS INC | $520,000 | +19.0% | 80,000 | 0.0% | 0.30% | -4.1% | |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $496,000 | +284.5% | 15,150 | +194.2% | 0.29% | +207.4% |
| QTNT | QUOTIENT LTD | $455,000 | +0.9% | 58,200 | 0.0% | 0.27% | -18.7% | |
| ADXS | ADVAXIS INC | $381,000 | +32.3% | 35,600 | 0.0% | 0.22% | +6.2% | |
| KURA | KURA ONCOLOGY INC | $369,000 | +130.6% | 59,114 | 0.0% | 0.22% | +85.3% | |
| BIIB | BIOGEN INC | $313,000 | +29.3% | 1,000 | 0.0% | 0.18% | +4.0% | |
| XNCR | XENCOR INC | $301,000 | +28.6% | 12,300 | 0.0% | 0.18% | +3.5% | |
| MACK | MERRIMACK PHARMACEUTICALS INC | $279,000 | +17.7% | 44,000 | 0.0% | 0.16% | -5.2% | |
| VCYT | New | VERACYTE INC | $263,000 | – | 34,567 | +100.0% | 0.15% | – |
| CELGZ | CELGENE CORPright 12/31/2030 | $248,000 | -28.7% | 238,214 | 0.0% | 0.14% | -42.7% | |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA INC | $242,000 | +27.4% | 27,000 | 0.0% | 0.14% | +2.2% | |
| WKHS | Buy | WORKHORSE GROUP INC | $217,000 | +110.7% | 30,000 | +100.0% | 0.13% | +69.3% |
| OPK | New | OPKO HEALTH INC | $214,000 | – | 20,202 | +100.0% | 0.12% | – |
| ICPT | INTERCEPT PHARMACEUTICALS INC | $214,000 | +15.7% | 1,300 | 0.0% | 0.12% | -6.7% | |
| CHRS | COHERUS BIOSCIENCES INC | $201,000 | +58.3% | 7,500 | 0.0% | 0.12% | +27.2% | |
| GNCA | GENOCEA BIOSCIENCES INC | $200,000 | +25.0% | 39,000 | 0.0% | 0.12% | +0.9% | |
| MDGN | New | MEDGENICS INC | $189,000 | – | 34,000 | +100.0% | 0.11% | – |
| ROKA | ROKA BIOSCIENCE INC | $175,000 | +21.5% | 252,307 | 0.0% | 0.10% | -2.9% | |
| CERS | CERUS CORP | $165,000 | 0.0% | 26,500 | 0.0% | 0.10% | -20.0% | |
| PRTK | PARATEK PHARMACEUTICALS INC | $145,000 | -6.5% | 11,150 | 0.0% | 0.08% | -24.8% | |
| TTHI | Sell | TRANSITION THERAPEUTICS INC | $36,000 | -83.2% | 23,866 | -83.6% | 0.02% | -86.5% |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -5,000 | -100.0% | -0.10% | – |
| RPTP | Exit | RAPTOR PHARMACEUTICAL CORP | $0 | – | -40,000 | -100.0% | -0.16% | – |
| RLYP | Exit | RELYPSA INC | $0 | – | -18,000 | -100.0% | -0.24% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -18,760 | -100.0% | -0.82% | – |
| HNSN | Exit | HANSEN MEDICAL INC | $0 | – | -528,142 | -100.0% | -1.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.